Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities: 2023-2024

Historic Total Current Liabilities for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $18.6 million.

  • Zhengye Biotechnology Holding's Total Current Liabilities was N/A to $18.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.6 million, marking a year-over-year change of. This contributed to the annual value of $18.6 million for FY2024, which is 12.42% down from last year.
  • As of FY2024, Zhengye Biotechnology Holding's Total Current Liabilities stood at $18.6 million, which was down 12.42% from $21.3 million recorded in FY2023.
  • Over the past 5 years, Zhengye Biotechnology Holding's Total Current Liabilities peaked at $21.3 million during FY2023, and registered a low of $18.6 million during FY2024.